Diagnostic Value of Pyrosequencing for the BRAFV600E Mutation in Ultrasound-Guided Fine-Needle Aspiration Biopsy Samples of Thyroid Incidentalomas
N/A
20 Years
N/A
20 Years
N/A
Not Enrolling
Both
Thyroid Neoplasms
Both
Thyroid Neoplasms
Trial Information
Diagnostic Value of Pyrosequencing for the BRAFV600E Mutation in Ultrasound-Guided Fine-Needle Aspiration Biopsy Samples of Thyroid Incidentalomas
Inclusion Criteria:
- Patients with thyroid nodule larger than 1 cm, or nodule smaller than 1 cm that
required further evaluation because of suspicious ultrasound findings
Exclusion Criteria:
- Patients who refuse participation.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Minho Shong, M.D., Ph.D.
Investigator Role:
Study Director
Investigator Affiliation:
Chungnam National University
Authority:
Korea: Food and Drug Administration
Study ID:
071027
NCT ID:
NCT00551486
Start Date:
June 2006
Completion Date:
December 2006
Related Keywords:
- Thyroid Neoplasms
- Pyrosequencing
- BRAFV600E mutation
- Thyroid incidentaloma
- Ultrasound-guided fine-needle aspiration biopsy
- Neoplasms
- Thyroid Neoplasms
- Thyroid Diseases
Name | Location |
|---|
